SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 58.17+3.9%Dec 4 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LLCF who wrote (79)3/17/1999 4:53:00 PM
From: LLCF  Read Replies (2) of 52153
 
Here's an updated Value spread sheet... more columns/names???

STK # Sh(mil)$(mil) $/shr Price Cap(mil) %$/Val 98'Exp* Revs*
OSIP 21.40 $22 1.04 3.5 $75 30% 31 19.50
BTRN 8.58 $20 2.33 2.25 $19 104% 17.2 8.00
*CEPH 28.73 $60 2.09 10 $287 21% 74.6 15.60
CORR 24.40 $50 2.05 8.5 $207 24% 73.2 41.90
TTP 13.10 $14 1.07 4 $52 27% Who knows?
MLNM 34.22 $150 4.38 34 $1,163 13% 139 133.68
INCY 29.34 $110 3.75 23 $674.77 16% 133 134.80
MBIO 19.60 $57 2.91 5 $98.00 58% 18.7 8.10
*AXPH 30.00 $75 2.50 4 $120.00 63% 203.58 47.40
*SIBI 9.00 $22 2.44 5 $45.00 49% ann. due out
ONXX 11.42 $20 1.75 6 $68.54 29% 30.618 11.31
*LGND 35.00 $41 1.17 9 $315.00 13% wait for ann.
*GLFD 19.56 $120 6.14 10.5 $205.33 58% 50.304 12.48
GLIA 10.12 $26 2.62 23 $232.71 11% 22.004 17.33
NPSP 12.50 $40 3.20 6.5 $81.22 49% 23.402 3.57
CTII 18.41 $12 0.65 1.5 $27.61 43% 22.261 8.80
CELG 16.45 $17 1.06 13 $213.84 8% wait for ann.
PARS 37.00 $4 0.11 1.25 $46.25 9% 6.109 1.50
*ALKS 24.90 $171 6.87 30 $747.00 23% 45.871 39.98
MEDX 31.30 $30 0.96 3.5 $109.56 27% 29.2 6.70
GELX 16.02 $110 6.87 17 $272.39 40% 41.145 32.66
PGNS 17.16 65 3.79 40 $686.20 9% 62.622 61.05
CGPI 8.58 10 1.17 10 $85.79 12% 16.01 3.00
NBIX 18.78 59 3.14 6 $112.67 52% 28.511 16.04
PCOP 20.24 52 2.57 9 $182.20 29% 105.667 92.21
*Revs & Exp in Millions

ALKS 9 month data,SIBI lawsuit not included,LGND warrants not included.
AXPH had 124.888 mill. Aquired R&D expenses.
GLFD stock buyback not included,CEPH recent financing not included.


DAK
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News